Clinical Trial Update: Evaluation of Compliance With Treatment by Genvoya in HIV Post-exposure Prophylaxis [Phase 3]

View source ↗

Summary

This trial update reports on adherence to Genvoya used for HIV post-exposure prophylaxis in a Phase 3 study that has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Genvoya (elvitegravir; cobicistat; emtricitabine; tenofovir alafenamide)

Snippet

Sponsor: Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux | Conditions: HIV Risk | Phase 3 | Status: COMPLETED